BioCentury
ARTICLE | Company News

Aspreva names Freytag CEO

July 12, 2007 1:24 AM UTC

Autoimmune company Aspreva (TSX:ASV; ASPV) hired J. William Freytag as CEO and chairman. Freytag is the former chairman, president and CEO of Myogen, which was acquired by Gilead (GILD) in 2006. He re...